NCT00618722View on ClinicalTrials.gov

Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Moderate or Severe Submental Fullness
Interventions
DRUG

Deoxycholic Acid Injection

DRUG

Placebo

Trial Locations (6)

Unknown

Investigational Site, Carina Heights

Investigational Site, Gold Coast

Investigational Site, Toorak

Investigational Site, Oakville

Investigational Site, Niagara Falls

Investigational Site, London

Sponsors
All Listed Sponsors
lead

Kythera Biopharmaceuticals

INDUSTRY

NCT00618722 - Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat | Biotech Hunter | Biotech Hunter